Curated medical-grade equipment and topical formulations for professional pore refinement.
Understanding the intersection of biotechnology, AI-driven diagnostics, and sustainable manufacturing.
The global pore-minimizing product market is projected to reach $1.5 billion by 2028. Demand is shifting from "instant camouflage" (primers) to "biological restructuring" (serums and RF treatments). As a leading exporter, Menuka Medical captures this trend by integrating clinical efficacy with mass-production scalability.
Modern consumers demand "Information Gain." We provide deep insights into sebum regulation via Saccharomycopsis Ferment Filtrate and Niacinamide synergies. Our R&D focuses on the skin microbiome, ensuring pore reduction is achieved by balancing the acid mantle rather than aggressive astringents.
Navigating EU-CE, FDA, and ASEAN cosmetic directives. Our manufacturing process ensures 100% traceability. For exporters, this means zero-risk localization. We provide the technical documentation required for global "Clean Beauty" certifications.
The Authority in Professional Medical Skincare & Dermatological Innovation
Founded in 2009, Jiangsu Menuka Medical Co., Ltd. is a leading innovator in the field of medical skincare and dermatological solutions. As a modern enterprise integrating R&D, intelligent manufacturing, clinical application, and global distribution, Menuka Medical is dedicated to advancing the future of professional skincare through science, safety, and innovation.
With years of expertise in dermatology and post-procedure skincare, Menuka Medical continuously develops advanced formulations and functional skincare products supported by patented technologies, clinical validation, and strict quality standards. Our products are specially designed to address sensitive skin conditions, aesthetic recovery, and professional dermatological care.
Today, Menuka Medical has established long-term partnerships with distributors, medical institutions, and skincare professionals across more than 15 countries and regions worldwide.
From chemical peeling to AI-assisted energy-based devices.
Integration of encapsulated Salicylic Acid and Bio-ferments to regulate sebaceous activity without irritation.
Utilizing Radio Frequency (RF) and Microneedling to stimulate collagen remodeling around the follicular opening, physically tightening the pore structure.
Developing IoT-connected devices that scan skin texture and provide real-time feedback on pore elasticity and sebum levels.
Our GMP-certified facility ensures every drop and device meets clinical standards.
Adapting pore-minimizing technology to diverse global markets and clinical settings.
Post-procedure recovery is crucial. Our barrier-repair probiotics and gentle pore vacuums are designed for use after chemical peels or laser resurfacing to minimize downtime and prevent rebound oiliness.
We provide full support for localized packaging, language translation for ingredient lists (INCI compliance), and market-entry certifications for Europe, the Middle East, and the Americas.
Pore issues vary by climate. In high-humidity regions (SE Asia), we focus on sebum control. In dry climates (Scandinavia), we focus on pore elasticity through hydration-based plumping.
Addressing the most common queries from distributors and dermatologists.
Advanced technology for comprehensive skin rejuvenation and maintenance.
Collaborate with a manufacturer that values science as much as you do. Together, we are shaping the future of dermatology skincare through science, innovation, and professional excellence.
Menuka Medical
